Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Mullen team present in Dubai this week for delivery of first EV vehicles. Mullen recently executed a 1-for-100 reverse stock ...

The sale by Berkshire Hathaway has changed the float of Apple stock, with more shares available to investors. Rules from ...

The union members, most of them based in Washington state, turned down a proposal to raise wages by 25% over four years, as ...

Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic ...

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Buying $100 In GME: If an investor had bought $100 of GME stock 5 years ago, it would be worth $1,741.04 today based on a ...

A study reveals the potential use of cannabis in biblical times, suggesting Jesus used it for healing and anointing practices ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...